1. Can arthroscopy be used for management of patients with acute sepsis of the native knee joint?
  2. Does the use of a tourniquet influence the incidence of surgical site infection (SSI) following arthroscopic surgery of extremity joints?
  3. How many arthroscopic procedures are reasonable for management of an infected ACL reconstruction prior to considering arthrotomy?
  4. How many arthroscopic procedures are reasonable for management of an infected ACL reconstruction prior to considering graft and hardware removal?
  5. Is the surgical management of a patient with infection following ACL reconstruction an emergency or can the patient be optimized prior to surgical intervention? If so, what needs to be optimized?
  6. Should a synovectomy routinely be performed during arthroscopic treatment of an acute infection following ACL reconstruction?
  7. Should autograft or allograft be soaked in an antiseptic or antibiotic solution prior to implantation during ACL reconstruction?
  8. Should culture samples be taken during arthroscopic treatment of a knee joint infection? If so, how many and from which area in the joint?
  9. Should routine Methicillin Resistant Staphylococcus aureus (MRSA) screening be in place for patients undergoing elective sports procedures?
  10. Should the graft and all hardware be removed in the treatment of patients with an acute infection following ACL reconstruction?
  11. Should the rehabilitation protocol be modified after surgical debridement of an infected ACL reconstruction? If yes, what changes should be made in regards to range of motion and weight bearing status?
  12. What diagnostic "algorithm" should be used to diagnose infection following ACL reconstruction?
  13. What is the best method for allograft sterilization that minimizes the incidence of postoperative infections and mechanical weakening of the graft?
  14. What is the most appropriate/effective sterilization method of an ACL graft dropped on the operating room floor during ACL reconstruction? Should the tissue instead be disposed and alternate graft acquired?
  15. What is the optimal duration of antibiotic treatment after surgical debridement of an infected ACL reconstruction? Should this be altered when autograft or allograft is retained?
  16. What perioperative antibiotic prophylaxis should be used in patients undergoing arthroscopic surgery who are Methicillin resistant Staphylococcus aureus (MRSA)  carriers?
  17. What perioperative antibiotic prophylaxis should be used in patients undergoing arthroscopic surgery without the use of implants or grafts? What about patients with penicillin allergy?
  18. What strategies should be employed to minimize recurrent infection of a previously infected joint during subsequent joint reconstructive (non-arthroplasty) procedures?
  19. What type of lavage solution should be used in patients with a native knee infection being treated with arthroscopy?
  20. When can patients safely undergo revision ACL reconstruction following treatment for prior infection?